Sponsor Pipeline

Soleno Therapeutics, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
0
Recruiting
1
Phase 3
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-14 NCT07450664
Observational Study of VYKAT™ XR in Patients With Prader-Willi Syndrome
Trial sites expanded: 15 -> 23 locations
Active Trials by Phase
Phase 3
1
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT05701774 Open-Label Extension Study of DCCR in Patients With Prader-Willi Syndrome Prader-Willi Syndrome Active, Not Recruiting
Not specified
NCT07450664 Observational Study of VYKAT™ XR in Patients With Prader-Willi Syndrome Prader-Willi Syndrome Enrolling by Invitation
Get alerts when Soleno Therapeutics, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free